What it is
Regulatory status: investigational peptide; not an FDA-approved drug or dietary supplement ingredient, and FDA has identified safety risks for compounded BPC-157
Mechanism evidence: animal
BPC-157 is a synthetic peptide promoted for tissue repair. Proposed angiogenic, nitric-oxide, and growth-factor pathways come mainly from laboratory and animal work; a validated human healing mechanism and effective dose have not been established.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: investigational peptide; not an FDA-approved drug or dietary supplement ingredient, and FDA has identified safety risks for compounded BPC-157
Mechanism evidence: animal
BPC-157 is an experimental peptide, not a proven recovery medicine. Animal findings and personal reports do not establish that oral or injected BPC-157 improves human surgical, tendon, or ligament healing.
Confidence: unsupported
Contraindications, interactions and clinical cautions from reviewed sources.
Human safety, pharmacokinetics, immunogenicity, impurity risk, reproductive effects, cancer-related risk, and route-specific dosing are not adequately characterized. FDA flags compounded BPC-157 for potential immunogenicity and peptide-impurity concerns.
This review does not automatically apply to:
Public protocols that include BPC-157. Open one to see the full context and source.
Dose and schedule patterns reported in public protocols; these are observations, not prescribing advice. Private and hidden usage is excluded.
Continue into interventions that appear alongside this one.